Vitamin D and hematinic deficiencies in patients with recurrent aphthous stomatitis
In Phase 3 trials (n=412), it produced a 15.2% reduction in visceral fat and a significant increase in IGF-1 (Falutz et al., JAMA 2007At French Peptides, it is available exclusively for research
Working with a registered dietitian nutritionist who has experience with GLP-1 medications can help you develop practical strategies for meeting your nutritional needs despite reduced appetite
While its main purpose is to build tolerance and minimise potential side effects, some patients may still notice early appetite changes or modest weight loss during this phase
Gao Y, Tao W, Wang S, Duan R, Zhang Z
That shift can support gradual weight loss without relying only on willpower